Alta Sciences

FEBRUARY 8, 2024

In this on-demand webinar, Ingrid Holmes , Vice President of Global Clinical Operations at Altasciences, and Dr. Gary G. Various psychomotor and neuropsychological tests, including the measurement of reaction time, divided attention, selective attention, and memory, may still be appropriate.

Clinical Trials 52

Clinical Trials Trials Clinical Pharmacology Clinical Development 52

Perficient: Drug Development

FEBRUARY 13, 2024

Learn about Adobe’s commitment to maintaining HIPAA-ready standards within commerce solutions and join Perficient and Adobe for a webinar hosted by CMSWire. EST Secure Digital Conversion: Unveiling Adobe’s HIPAA-Ready Commerce Solution webinar hosted by CMSWire. Register Today! Thursday, February 22 at 12:00 P.M.

Pharmacy 52

Pharmacy Regulations Science Marketing 52

Drug Discovery World

JANUARY 25, 2023

In this free webinar on February 17, 2023 you will hear from CBO/CDO of Adthera Bio, Stuart Curbishley, Chief Executive Officer of Cell & Gene Therapy Catapult, Matthew Durdy, Founder and CEO of Dark Horse Consulting, Anthony Davies, and Scientific Solutions Consultant at Benchling, Brian Fan.

Therapies 130

Therapies Drug Development Marketing Disease 130

Drug Discovery World

APRIL 3, 2023

Can NGS increase the chances of an oncology drug making it to market? Can NGS identify previously undruggable targets in cancer? How can the technology best be implemented in research labs?

RNA 130

RNA Medical Schools Drugs Clinical Trials 130

Drug Discovery World

APRIL 18, 2023

Join this free webinar to learn about the biggest challenges and opportunities facing the next-generation sequencing (NGS) oncology space. Can NGS increase the chances of an oncology drug making it to market? Can NGS identify previously undruggable targets in cancer? How can the technology best be implemented in research labs?

RNA 130

RNA Medical Schools Clinical Trials Drugs 130

Drug Discovery World

APRIL 4, 2023

Can NGS increase the chances of an oncology drug making it to market? Can NGS identify previously undruggable targets in cancer? How can the technology best be implemented in research labs?

RNA 130

RNA Medical Schools Drugs Clinical Trials 130

The Pharma Data

SEPTEMBER 15, 2020

Find out solutions to mitigate the impact from clinical supply chain risk and discover how to improve dynamic drug supply forecasting strategies. Join this webinar to learn how supply forecasting and interactive response technology can help biotech companies improve supply planning and distribution while reducing cost and risk.

Clinical Supply 52

Clinical Supply Clinical Trials Doctors Clinical Development 52

Fierce BioTech

JANUARY 12, 2024

Developing and Manufacturing Minitablets to Extend Drug Lifecycle pesurya Fri, 01/12/2024 - 12:38 Wed, 02/28/2024 - 11:00 Resource Type Webinar Robert Strickley, PhD Valjon Demiri, MSc Duration 60 Minutes Oral minitablets can offer several advantages in pharmaceutical applications, making them a valuable option in drug delivery.

Packaging 52

Packaging Compliance Drugs Drug Development 52

Fierce BioTech

OCTOBER 26, 2023

Are Gaps in Your Clinical Pharmacology Program Jeopardizing Your Drug’s Approval? pesurya Thu, 10/26/2023 - 14:05 Tue, 12/05/2023 - 11:00 Resource Type Webinar Julie Bullock, PharmD Krithika Shetty, PhD Blaire Osborn, Ph.D. png Listing Introduction Clinical pharmacology information comprises more than 50% of a drug label.

Clinical Pharmacology 52

Clinical Pharmacology Drug Development Regulations Marketing 52

Fierce BioTech

APRIL 4, 2024

Discover how leading organizations leverage AI to revolutionize operations and expedite drug development, ensuring faster access to life-saving treatments. Key Takeaways: Accelerate time-to-market by integrating AI-driven real-time visibility, streamlined workflows, and intelligent decision support. Click here to login.

Science 52

Science Compliance Drug Development Treatment 52

Conversations in Drug Development Trends

FEBRUARY 26, 2024

However, incorporating the patient experience into your design is one of the best ways to ensure your drug development program is a commercial success. It plays a significant role in patient recruitment and retention, both of which are vital to maintaining timelines, decreasing program costs, and gaining market approval.

Clinical Trials 59

Clinical Trials Trials Disease FDA Approval 59

Conversations in Drug Development Trends

FEBRUARY 22, 2023

Our rare disease team at Worldwide will be hosting a panel discussion webinar with patient advocates active in Rare Disease Day events to synthesize the most salient conversations taking place. See their conversation below and register for the webinar to hear more from these advocates!

Disease 52

Disease Clinical Trials Trials Treatment 52

Drug Discovery World

JUNE 23, 2023

FDA approves first gene therapy for Duchenne muscular dystrophy Sarepta Therapeutics’ Elevidys has become the first gene therapy for Duchenne muscular dystrophy (DMD) to gain marketing authorisation in the US.

FDA Approval 130

FDA Approval Therapies Packaging Drugs 130

Drug Discovery World

OCTOBER 1, 2024

What you will learn: Where is the opportunity in the neuroscience market? How to uncover the best research tools to boost the development of new treatments How to recognise and tackle barriers in neuroscience research What are the technologies that can help create efficiencies and get to market faster?

Science 130

Science Therapies Marketing Production 130

Perficient: Drug Development

OCTOBER 27, 2023

The webinar covered three pivotal aspects: Seamless Migration, Future-Ready Strategies, and the PWA Revolution. Seamless Migration: Composable Storefronts and Accelerators The webinar initiated with a comprehensive exploration of seamless migration strategies. The added assurance of SAP’s managed support promises stability.

Compliance 105

Compliance Licensing Marketing Licensing 105

Drug Discovery World

MARCH 29, 2023

Regulatory data protection (RDP) period RDP refers to the time when generic drug makers cannot refer to an innovator drug’s data to obtain a marketing authorisation 2.

Clinical Trials 130

Clinical Trials Biosimilars Pharma Companies Production 130

Agency IQ

JULY 8, 2024

Several webinars and training sessions are geared towards ISO identification of medicinal products (IDMP) standards which is referred to as Substance, Product, Organization, Referentials (SPOR) data management services. Some “add-on” regulatory data protection may also be converted to market exclusivity.

Regulations 40

Regulations Pharmaceuticals Production Compliance 40

Alta Sciences

MARCH 21, 2024

Watch Now The Altascientist: Central Nervous System Early-phase development of CNS-acting drugs is a complex, challenging undertaking. In this article, we provide a detailed overview of the multiple facets you need to consider during the planning and conduct of your CNS-active drug development.

Clinical Trials 40

Clinical Trials Trials FDA Drug Development 40

Fierce BioTech

OCTOBER 26, 2023

Separating the Science from the Fiction: Bringing the Lab of the Future to In Vivo Studies swheeler Thu, 10/26/2023 - 12:09 Thu, 12/07/2023 - 14:00 Resource Type Webinar Julie Morrison Ian Levine Jason M.

Science 52

Science Drug Development Research Marketing 52

The Pharma Data

SEPTEMBER 9, 2020

We respect your privacy, by clicking “Download Your Copy” you will receive our e-newsletter, including information on Podcasts, Webinars, event discounts, online learning opportunities and agree to our User Agreement. Transition to advanced analytics platforms to accelerate a product’s time-to-market.

Production 52

Production Laboratories Compliance Government 52

Agency IQ

MAY 3, 2024

Title Type Comments Close Key Information and Facilitating Understanding in Informed Consent Guidance for Sponsors, Investigators, and Institutional Review Boards Draft Guidance April 30 Early Alzheimer’s Disease: Developing Drugs for Treatment Draft Guidance May 13 Select Updates for the Premarket Cybersecurity Guidance: Section 524B of the (..)

FDA 40

FDA Science Regulations Clinical Trials 40

Perficient: Drug Development

OCTOBER 4, 2023

Tailor offers according to emerging trends and customer pain points through market research. Limited Marketing Resources: Leverage digital marketing and social media to cost-effectively reach a broader audience. Collaborate with complementary businesses for co-marketing opportunities.

Compliance 52

Compliance Government Production Regulations 52

Drug Discovery World

JUNE 7, 2023

What can we expect from the cell & gene therapy market? Is it true that the next era will belong to antibody drug conjugates? Will AI be key to expediting the drug discovery process and what role will data science have? Panellists will discuss the following questions: Where will the opportunities be in 2024?

DNA 130

DNA Clinical Trials Drugs Vaccine 130

Perficient: Drug Development

FEBRUARY 27, 2024

Imagine this: You are a marketer at a medical device organization. It’s every marketer’s dream. Let’s look at a few ways medical device marketers can supercharge the digital product catalogs. Your products are cutting-edge, innovative, and best-in-class. Many of us remember the days of paper catalogs and brochures.

Production 52

Production Testimonials Marketing Science 52

Alta Sciences

APRIL 17, 2024

Five Promising Treatment Areas in Early-Phase Drug Development in 2024 aasimakopoulos Wed, 04/17/2024 - 15:52 Early-phase drug development is an ever-changing landscape, as emerging science leads to new promising areas of research for the treatment of human health issues.

Drug Development 52

Drug Development Treatment FDA Approval Drugs 52

Agency IQ

AUGUST 23, 2024

At a high level, the establishment of OPEQ brought together previously disparate offices involved in pre-market review (the Office of Device Evaluation and its divisions) and post-market work related to compliance and surveillance (the Office of Compliance) and Office of Surveillance and Biometrics).

FDA 40

FDA Laboratories Regulations Clinical Trials 40

Agency IQ

MARCH 1, 2024

Start Date End Date Event Event Type Center 02/26/2024 02/26/2024 FDA/CDER and American Association of Pharmaceutical Scientists (AAPS) Hybrid Public Workshop Public CDER 02/27/2024 02/27/2024 FDA Oncology Center of Excellence Presents: Conversations on Cancer, Black History Month Program: “Real Talk: Our Stories as Black Oncologists at the FDA” Webcast (..)

FDA 40

FDA Science Clinical Trials Regulations 40

Agency IQ

AUGUST 2, 2024

Happy 40 th Birthday, generic drugs: September 24 will mark the 40 th anniversary of the 1984 signing of the Hatch-Waxman Act, which created a formal pathway for the approval of generic drugs. We expect the FDA to mark the occasion, especially since drug pricing continues to be such a potent issue in the Presidential election.

FDA 40

FDA Science Regulations Biosimilars 40

The Connected Lab

JUNE 2, 2021

The impact of these technologies on drug development, production and logistics is so disruptive that many consider the sector to be entering a fourth industrial revolution, known as Pharma 4.0. Here, we look at how Pharma 4.0 Join our Laboratory 4.0 Digitalization and Internet of Laboratory Things Strategies to Enrich Industry 4.0

Pharmaceuticals 52

Pharmaceuticals Laboratories Pharmaceutical Companies Production 52

Perficient: Drug Development

JULY 18, 2023

The uncertain economy has also caused organizations to cut back on travel budgets – making webinars more attractive. It’s no wonder that many events have had lower post-pandemic attendance rates as people become increasingly wary about where and how they invest their time.

Research 52

Research Marketing 52

Alta Sciences

JUNE 9, 2023

Accelerating Global Drug Development Timelines With Ethnobridging rmaloney Mon, 06/12/2023 - 16:07 HTML Safe Strategy to Save Time and Money Avoid repeating Phase I studies for drugs intended for the Asian market. Download your copy today. In this complimentary webinar , Mel B. Watch the webinar.

Drug Development 40

Drug Development Clinical Trials Biosimilars Pharmacokinetics 40

Conversations in Drug Development Trends

FEBRUARY 28, 2023

Four decades later, Rob realized he had coincidentally dedicated his life — a life saved because of that charity — to driving life-saving treatments to market in the very same way, as the Executive Director of Uplifting Athletes. We are joining these researchers and patient communities on a decades-long journey to get a drug to market.

Clinical Trials 52

Clinical Trials Disease Trials Research 52

Agency IQ

APRIL 12, 2024

In drug development, biochemical assays might be used to determine a product’s binding affinity to a target receptor of interest, along with the strength, stability and duration of the target-ligand complex after the product binds to the receptor. What does progressive implementation of a potency assurance strategy mean? If so, how?

Production 40

Production FDA Therapies Biochemical Assays 40

Agency IQ

JUNE 2, 2023

6/27/2023 Notification FDORA, Section 3201 Within 180 days of the passage of FDORA, all biologics and biosimilars sponsors must submit a written notice to the FDA of all actively marketed products (i.e., These inspections will be routine surveillance rather than inspections as part of an approval application.

FDA 40

FDA Science Regulations Production 40

Agency IQ

FEBRUARY 2, 2024

Start Date End Date Event Event Type Center 01/10/2024 01/10/2024 FDA Oncology Center of Excellence Presents: Conversations on Cancer: “Bringing Innovation to People Facing Cancer” Webcast Office of the Commissioner 01/26/2024 01/26/2024 Medical Device Sterilization Town Hall: FDA Activities and Challenges in Reducing Reliance on Ethylene Oxide (EtO) (..)

FDA 40

FDA Science Clinical Trials Regulations 40

PPD

SEPTEMBER 16, 2024

The convergence of real-world data (RWD), technology and artificial intelligence (AI) is playing a vital role in accelerating drug development. In a recent panel discussion at DIA Global , our experts explored how these elements are reshaping clinical research and drug discovery.

Clinical Development 52

Clinical Development Clinical Trials Clinical Research Trials 52

Drug Discovery World

JANUARY 19, 2023

The market for cell and gene therapies has grown rapidly over the last few years and will likely continue, with forecasts predicting it will grow 39% to around $42.56 The post Early phase support for plasmid DNA supply to secure future manufacturing appeared first on Drug Discovery World (DDW).

DNA 130

DNA Therapies Assay Development Production 130